• PTG

Packaging Technology Group (PTG) Expands National Footprint with Opening of New Louisville, Kentucky Location

June 9, 2020 – Greater Boston, MA and Louisville, KY- Packaging Technology Group, Inc., (PTG), a leading provider of thermalpackaging solutions for the biopharmaceutical and life sciences sector,announced today the opening of a new location in Louisville, Kentucky.  Thenewly constructed facility, called PTG Kentucky, is located at 1001 GlengarryDrive, Fairdale, KY. Click here to read full press release.

By |2020-06-09T19:47:56+00:00June 9th, 2020|News|Comments Off on Packaging Technology Group (PTG) Expands National Footprint with Opening of New Louisville, Kentucky Location
  • allen & gettisen

Safety 1st Partners with Allen & Gerritsen to Create “Signs of the Times” for Parents Working From Home

Allen & Gerritsen (A&G) and Safety 1st, a leading provider of child safety products, today unveiled “Signs of the Times,” a creative campaign rooted in empathy and humor that has refreshed the brand’s iconic “Baby on Board” sign for parents working from home during the novel coronavirus (COVID-19) pandemic. Created by parents, for parents, the campaign assets include both video and static backgrounds for virtual meetings, as well as Instagram stickers and GIFs. Click here to read full press release.

By |2020-05-13T19:39:20+00:00May 13th, 2020|News|Comments Off on Safety 1st Partners with Allen & Gerritsen to Create “Signs of the Times” for Parents Working From Home
  • Vero

Home Use of GENOSYL® Delivery System (DS) to Administer GENOSYL® (nitric oxide) gas for Inhalation for the Treatment of Pulmonary Hypertension Complicated by COVID-19 Infection Published in American Journal of Respiratory and Critical Care Medicine

Clinicians report on first at-home treatment of COVID-19 patient with VERO Biotech’s GENOSYL DS, an innovative, tankless delivery system for inhaled nitric oxide.  Click here to read full press release.

By |2020-05-06T22:37:03+00:00May 6th, 2020|News|Comments Off on Home Use of GENOSYL® Delivery System (DS) to Administer GENOSYL® (nitric oxide) gas for Inhalation for the Treatment of Pulmonary Hypertension Complicated by COVID-19 Infection Published in American Journal of Respiratory and Critical Care Medicine
  • Vero

Atlanta-based biotech provides innovative portable inhaled nitric oxide delivery system; Company is hiring in Atlanta to meet increased demand; Makes emergency treatment protocols available to Atlanta hospitals

VERO Biotech LLC, an Atlanta, Georgia-based biotechnology company focused on saving lives, alleviating suffering, and improving the health economics of care, today announced that it is doubling down on its commitment to support the treatment of patients afflicted with complications of COVID with GENOSYL® DS, the first and only FDA-approved tankless system for the delivery of inhaled nitric oxide.  Click here to read full press release.

By |2020-04-08T22:31:45+00:00April 8th, 2020|News|Comments Off on Atlanta-based biotech provides innovative portable inhaled nitric oxide delivery system; Company is hiring in Atlanta to meet increased demand; Makes emergency treatment protocols available to Atlanta hospitals
  • Vero

FDA Grants VERO Biotech Expanded Access Emergency Use for the Treatment of Patients with COVID-19, with the GENOSYL® DS, the First and Only FDA-Approved Tankless System for the Delivery of Inhaled Nitric Oxide

The recently FDA-approved GENOSYL® inhaled nitric oxide may have pulmonary and antiviral benefits in treating pulmonary hypertension and acute infectious diseases associated with the novel coronavirus1.  Click here for full press release

By |2020-03-26T23:45:55+00:00March 26th, 2020|News|Comments Off on FDA Grants VERO Biotech Expanded Access Emergency Use for the Treatment of Patients with COVID-19, with the GENOSYL® DS, the First and Only FDA-Approved Tankless System for the Delivery of Inhaled Nitric Oxide
  • Vero

VERO Biotech Announces First Patient With COVID-19 Infection Complicating Pulmonary Hypertension Treated with GENOSYL® DS, the First and Only FDA-Approved Tankless System for the Delivery of Inhaled Nitric Oxide

Treatment informs FDA approval for emergency expanded access use for GENOSYL® inhaled nitric oxide.  Click here to read full press release

By |2020-03-24T23:52:33+00:00March 24th, 2020|News|Comments Off on VERO Biotech Announces First Patient With COVID-19 Infection Complicating Pulmonary Hypertension Treated with GENOSYL® DS, the First and Only FDA-Approved Tankless System for the Delivery of Inhaled Nitric Oxide
  • Seaman Paper

Seaman Paper’s “Let There Be (LED) Light” Program Earns AF&PA Sustainability Award

Sustainability is one of Seaman Paper’s core values. As an industry leader, we strive to make progress toward a cleaner planet via initiatives that significantly minimize the impact we have on the environment. One example is our “Let There Be (LED) Light” program, a switch to LED lighting that reduced our annual electricity consumption by an estimated 1,263,000 kilowatt hours (kWh).  This initiative earned the attention of the American Forest & Paper Association (AF&PA), who recognized our progress by honoring [...]

By |2020-02-07T20:02:02+00:00February 7th, 2020|News|Comments Off on Seaman Paper’s “Let There Be (LED) Light” Program Earns AF&PA Sustainability Award
  • Segue

Segue Manufacturing Services LLC Receives 2020 Best of Lowell Award Lowell Award Program Honors the Achievement

LOWELL January 14, 2020 -- Segue Manufacturing Services LLC has been selected for the 2020 Best of Lowell Award in the Electronic Parts Supplier category by the Lowell Award Program.  Click here to read press release.

By |2020-01-14T22:40:36+00:00January 14th, 2020|News|Comments Off on Segue Manufacturing Services LLC Receives 2020 Best of Lowell Award Lowell Award Program Honors the Achievement
  • Vero

VERO Biotech Receives US FDA Approval of GENOSYL® for the Delivery of Inhaled Nitric Oxide

DECEMBER 20, 2019 The GENOSYL® inhaled nitric oxide approval represents the first and only FDA-approved tankless delivery system and is an important new development in the clinical application of inhaled nitric oxide. Click here to read more.

By |2020-02-13T18:38:21+00:00December 20th, 2019|News|Comments Off on VERO Biotech Receives US FDA Approval of GENOSYL® for the Delivery of Inhaled Nitric Oxide

A&G is One of the Most Awarded Agencies at 2019 Hatch Competition

Allen & Gerritsen was one of the top agencies bringing home Hatch Bowls at the 59th Annual Francis W. Hatch Awards, presented by The Ad Club for creative excellence in advertising. The Hatch Awards are New England’s most prestigious awards for creative branding and marketing. Click here to read more.

By |2020-02-07T19:45:14+00:00October 30th, 2019|News|Comments Off on A&G is One of the Most Awarded Agencies at 2019 Hatch Competition
Go to Top